SCHEMBL4829062

SCHEMBL4829062

CCN1C(=O)C(C)(C)c2cc3[nH]c(-c4n[nH]cc4NC(=O)c4ccno4)nc3cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.50
AURKB Q96GD4 2/20 0.50
CHEK1 O14757 1/20 0.34
SRC P12931 1/20 0.34
CDK2 P24941 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34
GSK3B P49841 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
ITK Q08881 2/20 0.33
CSF1R P07333 1/20 0.32
MGAT2 Q10469 1/20 0.31
ACE2 Q9BYF1 1/20 0.31
HDAC1 Q13547 1/20 0.30
PKM P14618 1/20 0.30
HTR2A P28223 1/20 0.30
PDE4A P27815 1/20 0.30
PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4827459 0.88 AURKA (0.50) AURKAAURKBKMT2AMEN1MAPK1
SCHEMBL4823345 0.87 AURKA (0.52) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4830704 0.86 AURKA (0.51) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4829059 0.86 AURKA (0.53) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4830755 0.86 AURKA (0.48) AURKAAURKBKMT2AMEN1MAPK1
SCHEMBL4829418 0.85 AURKA (0.58) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4829180 0.85 AURKA (0.51) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4829419 0.85 AURKA (0.51) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4826008 0.85 AURKA (0.52) AURKAAURKBCHEK1SRCCDK2
SCHEMBL4829392 0.85 AURKA (0.50) AURKAAURKBCHEK1SRCCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US claimed
US-7462639-B2 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma HOFFMANN-LA ROCHE INC. (US) 2008-12-09 US disclosed
US-20060235065-A1 Aminopyrazole derivatives HOFFMANN-LA ROCHE INC. 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235065-A1 Aminopyrazole derivatives CYP3A43, CYP3A5, CYP3A4 AURKA 742/4885AURKB 1096/4885CHEK1 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.